Sangart
San Diego
About Sangart
Sangart, Inc. is a privately held biopharmaceutical company focused on being the global scientific, clinical and commercial leader in oxygen-therapeutic agents, providing innovative products to patients in need. Sangart was founded in 1998 based on discoveries arising from over two decades of research in red blood cell substitutes and the mechanisms of oxygen transport by cell-free hemoglobin solutions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $294.5M
- Funding stage: Late Stage Venture
- Last round: Series G (May 2012)
- Website: sangart.com
- Phone: 858-450-2400
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Canonical: https://fsome.com/organization/sangart-2421283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.